Abstract
Targeted gene transfer by nonviral vectors can be achieved through incorporation of specific ligand(s) into the vectors. In this study, the effects of incorporation of an anti-ErbB2 single-chain antibody fragment (ScFv) into nonviral vectors for targeted gene delivery were investigated. The ML39 ScFv, selected from a human ScFv phage display library and affinity matured in vitro ( K d=1×10−9 M), was used as ligand specific for the extracellular domain of the tumor surface protein, ErbB2. Two approaches were taken: (a) development of a vector that is composed of a bifunctional fusion protein capable of binding DNA with the ErbB2-specific ML39 ScFv at its N-terminus and a truncated form of human protamine at its C-terminus, and (b) formulation and evaluation of delivery vectors consisting of three independent components including ML39 ScFv, protamine, and cationic lipids. We demonstrate that fusion proteins comprised of the ML39 ScFv and a truncated form of protamine, denoted as ScFv-P-S, can selectively deliver exogenous DNA into ErbB2(+) cells, with an 8- to 10-fold increase in expression levels of the luciferase reporter gene in ErbB2(+) cells as compared to ErbB2(−) cells. In addition, vectors formulated by appropriately mixing DNA, ScFv, protamine, and lipids in vitro could even more efficiently deliver the reporter gene into ErbB2(+) cells with approximately 5-fold increase in gene expression in ErbB2(+) cell as compared to ErbB2(−) cells. Expression and refolding of the ScFv fusion proteins, in addition to determination of optimal conditions for vector development using these approaches, are discussed. Cancer Gene Therapy (2001) 8, 555–565
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schnierle BS, Groner B . Retroviral-targeted delivery Gene Ther 1996 3: 1069–1073
Lee RJ, Huang L . Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell–specific gene transfers J Biol Chem 1996 271: 8481–8487
Lee RJ, Huang L . Lipidic vectors systems for gene transfer Crit Rev Ther Drug Carrier Syst 1997 14: 173–206
Felgner PL, et al . Lipofection: a highly efficient, lipid-mediated DNA transfection procedure Proc Natl Acad Sci USA 1987 84: 7413–7417
Felgner PL . Improvements in cationic liposomes for in vivo gene transfer Hum Gene Ther 1996 7: 1791–1793
Michael SI, Curiel DT . Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway Gene Ther 1994 1: 223–232
Wagner E, Cotten M, Foisner R, Birnstiel ML . Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells Proc Natl Acad Sci USA 1991 88: 4255–4259
Zenke M, et al . Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells Proc Natl Acad Sci USA 1990 87: 3655–3659
Perales JC, et al . Gene transfer in vivo : sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake Proc Natl Acad Sci USA 1994 91: 4086–4090
Chowdhury NR, et al . Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy J Biol Chem 1993 268: 11265–11271
Ferkol T, et al . Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor J Clin Invest 1995 95: 493–502
Harbottle RP, et al . An RGD oligolysine peptide: a prototype construct for integrin-mediated gene delivery Hum Gene Ther 1998 9: 1037–1047
Fominaya J, Wels W . Target cell–specific DNA transfer mediated by a chimeric multidomain protein. Novel nonviral gene delivery system J Biol Chem 1996 271: 10560–10568
Chen SY, Zani C, Khouri Y, Marasco WA . Design of a genetic immunotoxin to eliminate toxin immunogenicity Gene Ther 1995 2: 116–123
Lee KF, et al . Requirement for neuregulin receptor erbB2 in neural and cardiac development Nature 1995 378: 394–398
Salomon DS, Brandt R, Ciardiello F, Normanno N . Epidermal growth factor–related peptides and their receptors in human malignancies Crit Rev Oncol Hematol 1995 19: 183–232
Hynes NE, Stern DF . The biology of erbB-2/neu/HER-2 and its role in cancer Biochim Biophys Acta 1994 1198: 165–184
Karunagaran D, et al . ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer EMBO J 1996 15: 254–264
Uherek C, Fominaya J, Wels W . A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell–specific gene delivery J Biol Chem 1998 273: 8835–8841
Schier R, et al . Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site J Mol Biol 1996 263: 551–567
Reiter Y, Pastan I . Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis Trends Biotechnol 1998 16: 513–520
Reiter Y, et al . Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment J Biol Chem 1994 269: 18327–18331
Buchner J, Pastan I, Brinkmann U . A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies Anal Biochem 1992 205: 263–270
Bera TK, Onda M, Brinkmann U, Pastan I . A bivalent disulfide-stabilized Fv with improved antigen binding to erbB2 J Mol Biol 1998 281: 475–483
Gazdar AF, et al . Characterization of paired tumor and nontumor cell lines established from patients with breast cancer Int J Cancer 1998 78: 766–774
Peng KW, Russell SJ . Viral vector targeting Curr Opin Biotechnol 1999 10: 454–457
Cotten M, Wagner E . Nonviral approaches to gene therapy Curr Opin Biotechnol 1993 4: 705–710
Brown N . Liposome advances: progress in drug and vaccine delivery. Fourth International CDDR Conference, December 13–17, 1999 Gene Ther 2000 7: 635–636
Cheng PW . Receptor ligand–facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin Hum Gene Ther 1996 7: 275–282
Xu L, et al . Transferrin liposome–mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts Hum Gene Ther 1999 10: 2941–2952
Wu GY, Wu CH . Receptor-mediated gene delivery and expression in vivo J Biol Chem 1988 263: 14621–14624
Sorgi FL, Bhattacharya S, Huang L . Protamine sulfate enhances lipid-mediated gene transfer Gene Ther 1997 4: 961–968
Li S, Huang L . In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes Gene Ther 1997 4: 891–900
Mirzabekov T, et al . Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5 Nat Biotechnol 2000 18: 649–654
Simoes S, et al . Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusogenic peptides Gene Ther 1998 5: 955–964
Plank C, Tang MX, Wolfe AR, Szoka FC Jr . Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes Hum Gene Ther 1999 10: 319–332
Yamazaki Y, et al . Polycation liposomes, a novel nonviral gene transfer system, constructed from acetylated polyethylenimine Gene Ther 2000 7: 1148–1155
Sheets MD, Amersdorfer P, Finnern R, et al . Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens Proc Natl Acad Sci USA 1998 95: 6157–6162
de Haard HJ, van Neer N, Reurs A, et al . A large nonimmunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high-affinity antibodies J Biol Chem 1999 274: 18218–18230
Vaughan TJ, Williams AJ, Pritchard K, et al . Human antibodies with subnanomolar affinities isolated from a large nonimmunized phage display library Nat Biotechnol 1996 14: 309–314
Acknowledgements
We thank Quan Zhu (IntraImmune Therapies, Lexington, MA) for assistance in the design of the truncated human protamine polypeptide used in these studies. This work was supported, in part, by a Dana-Farber Cancer Institute Women's Cancer Program grant. X. Li was supported by a fellowship from the Canadian Medical Research Council. W. Marasco has a financial interest in Abgenix.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, X., Stuckert, P., Bosch, I. et al. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells. Cancer Gene Ther 8, 555–565 (2001). https://doi.org/10.1038/sj.cgt.7700337
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700337
Keywords
This article is cited by
-
Enzymatic ligation of an antibody and arginine 9 peptide for efficient and cell-specific siRNA delivery
Scientific Reports (2021)
-
High-level expression, purification, and characterization of bifunctional ScFv-9R fusion protein
Applied Microbiology and Biotechnology (2014)
-
RNAi Therapy: Antibodies guide the way
Gene Therapy (2006)